DE2842691A1 - Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field - Google Patents
Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic fieldInfo
- Publication number
- DE2842691A1 DE2842691A1 DE19782842691 DE2842691A DE2842691A1 DE 2842691 A1 DE2842691 A1 DE 2842691A1 DE 19782842691 DE19782842691 DE 19782842691 DE 2842691 A DE2842691 A DE 2842691A DE 2842691 A1 DE2842691 A1 DE 2842691A1
- Authority
- DE
- Germany
- Prior art keywords
- irradiation
- magnetic field
- wavelengths
- substance
- simultaneous application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
Abstract
Description
Energetische Anregung biologischer Arzneimittel Energetic stimulation of biological medicines
In der Homöopathie und in der anthroposophischen Medizin versucht man die Wirksamkeit von Arzneimitteln durch "Dynamisierung" zu verbessern. Es werden dabei die Arzneimittellösungen in Richtung des Erdmagnitismus geschüttelt, so daß mechanische und magnetische Energie auf das Arzneimittel einwirken.Tried in homeopathy and in anthroposophic medicine to improve the effectiveness of drugs through "dynamization". It will thereby shaking the drug solutions in the direction of earth magnitism, so that mechanical and magnetic energy act on the medicine.
Erfindungsgemäß werden nun zur Aktivierung der Arzneimittelwirkung elektromagnetische Wellen mit oder ohne gleichzeitige Anwendung eines künstlichen elektrischen Magnetfeldes verwendet.According to the invention are now used to activate the drug effect electromagnetic waves with or without simultaneous application of an artificial one electric magnetic field used.
Die Bestrahlung erfolgt mit Wellenlängen, die dem Absorptions-Spektrum bzw. Emmlssionsspektrum des zu bestrahlenden biologischen Wirkstoffes bzw. Gemisches entsprechen. Dazu werden vor der Bestrahlung die Spektren nach bekannten Verfahren bestimmt (vergl. Biochemisches Taschenbuch von H.M. RAUEN , Teil 2, S. 553 u.f., Springer-Verlag). Die Bestrahlung erfolgt sodann mit einem konttuierlichen Spektrum oder aber auch mit gefilterten Wellenlängen die den hauptsächlichen einzelnen Absorptionslinien entsprechen. Es werden dabei Wellenlängen im Bereich des sichtbaren Lichts wie auch der unsichtbaren Strahlung von Gamma-Strahlen, UV-Strahlen und andererseits auch langwelligen Infrarotstrahlen verwendet. Die Bestrahlung kann mit diffusen Strahlen wie auch mit kohärenter Lafserstrahlung erfolgen.The irradiation takes place with wavelengths that correspond to the absorption spectrum or emission spectrum of the biological active ingredient or mixture to be irradiated correspond. For this purpose, the spectra are prepared using known methods before the irradiation determined (see biochemical pocket book by H.M. RAUEN, part 2, p. 553 and f., Springer-Verlag). The irradiation then takes place with a continuous spectrum but also with filtered wavelengths the main individual absorption lines correspond. There are wavelengths in the range of visible light as well the invisible radiation of gamma rays, UV rays and on the other hand also uses long-wave infrared rays. The irradiation can be done with diffuse rays as well as with coherent Lafs radiation.
Sie kann kontinuierlich wie auch durch Impulse stattfinden.It can take place continuously as well as through impulses.
Zusätzlich kann parallel oder senkrecht zur Strahlenrichtung ebenfalls kontinuierlich oder diskontinuierlich ein künstliches Magnetfeld auf das Bestrahlungsobjekt einwirken. Dieses wird durch eine elektrische Spule bekannterweise erzeugt.In addition, it can also be parallel or perpendicular to the beam direction continuously or discontinuously an artificial magnetic field on the irradiated object act. This is known to be generated by an electrical coil.
Die Intensität und Dauer der Bestrahlung muß auf den zu bestrahlenden biologischen Stoff abgestimmt werden. Es darf keine Denaturierung eintreten. Dies läßt sich durch Vergleich der Absorptionsspektren feststellen, die vor und nach der Bestrahlung gewonnen werden.The intensity and duration of the irradiation must depend on the one to be irradiated biological substance to be matched. There must be no denaturation. this can be determined by comparing the absorption spectra that are before and after the irradiation can be obtained.
Die Bestrahlung, insbesondere von pulverisierten Stoffen, kann bei ruhendem Objekt erfolgen, bei flüssigen Arzneimitteln jedoch auch im Durchlaufverfahren. Bei Bestrahlung von Flüssigkeiten wird eine Durchlaufküvette bzw.-Kammer mit Quarzfenster verwendet, durch die die Bestrahlung erfolgt. Die Schichtdicke des Flüssigkeitsstromes sollte 10 mm nicht übersteigen.Irradiation, especially of pulverized substances, can be used in a stationary object, but also in the case of liquid pharmaceuticals in a continuous process. When irradiating liquids, a flow cell or chamber with a quartz window is used used, through which the irradiation takes place. The layer thickness of the liquid flow should not exceed 10 mm.
Der Flüssigkeitsstrom kann durch den Hohlraum des Elektromagneten geleitet werden, wobei die Spule eine Aussparung für die senkrecht zum Magnetfeld erfolgende Bestrahlung besitzt. Bei parallel zur Strahlung ausgerichtetem Magnetfeld wird die Strahlung durch den Hohlraum der Magnetspule geleitet.The flow of liquid can flow through the cavity of the electromagnet be conducted, the coil having a recess for the perpendicular to the magnetic field pending irradiation. With a magnetic field aligned parallel to the radiation the radiation is guided through the cavity of the solenoid.
Es werden vorwiegend biologische Arzneimittel in dieser Weise behandelt, insbesondere Organotherapeutika, Phytotherapeutika und Präparate aus Mikroorganismen. Dazu sind auch Vitamine, Fermente, Enzyme und Hormone zu zählen. Speziell ist das Verfahren für makromolekulare Organextrakte vorgesehen, die durch ein besonderes Verfahren zum gesteuerten chemischen Aufschluß von biologischen Geweben unter Verwendung von Dämpfen chemischer Reagenzien erhalten worden sind, wobei man die pulverförmigen Substrate mit dem, den Aufschluß bewirkenden Reagenz, dessen Siedepunkt bei atmosphärischem Druck über der Normaltemperatur liegt, vorzugsweise konzentrierte Schwefelsäure, Essigsäure, Ameisensäure oder Diäthylamin in einem geschlossenen System zusammen oder getrennt voneinander einem solchen Vakuum aussetzt, welches die Überführung des aufschliessenden Mittels in die dampfförmige Phase ermöglicht, und nachdem der gewünschte Aufschluß des Substrates erreicht ist, das nicht verbrauchte Reagenz wieder entfernt, wobei man vorzugsweise von tiefgekühlten oder gefriergetrockneten pulverisierten Organgeweben ausgeht und man das dampfförmige chemische Reagenz aus einer vorbestimmten Menge durch Absenken des Vakuums zunächst auf dem Substrat niederschlägt und nach der gewünschten Einwirkung das überschüssige Reagenz durch Erhöhung des Vakuums wieder entfernt.Mainly biological drugs are treated in this way, in particular organotherapeutic agents, phytotherapeutic agents and preparations made from microorganisms. This also includes vitamins, ferments, enzymes and hormones. It is special Process for macromolecular organ extracts provided by a special Method for the controlled chemical digestion of biological tissues using of vapors of chemical reagents, being the powdery ones Substrate with the reagent causing the digestion, its boiling point at atmospheric Pressure is above normal temperature, preferably concentrated sulfuric acid, Acetic acid, formic acid or diethylamine together in a closed system or separately from each other to such a vacuum that the transfer allows the digesting agent in the vapor phase, and after the the desired digestion of the substrate is achieved, the reagent that has not been used removed again, preferably of frozen or Freeze-dried powdered organ tissue runs out and you get the vaporous chemical reagent from a predetermined amount by lowering the vacuum first precipitates on the substrate and after the desired action the excess Reagent removed again by increasing the vacuum.
Beispiel 1: Es sollen 2 g Trockenpulver aus foetaler Rinderleber, die nach dem geschilderten Verfahren der wasserfreien Säuredampflyse im Vakuum bei Normaltemperatur gewonnen wurde, energetisch angeregt werden. Dazu wird zunächst das Absorptionsspektrum photometrisch bestimmt, sodann die Bestrahlung mit einer Strahlenquelle durchgeführt, welche die Wellenlängei bzw. Frequenzen der hauptsächlichen Absorptionsmaxima enthalten. Das Trockenpulver wird in einer sterilen Küvette in einer Schichtdicke von 2 mm ausgelegt und mit einer Quarzplatte bedeckt. Die Bestrahlung erfolgt mit einer Strahlenquelle mit Wellenlängen zwischen 200 bis 1000 nm bei Abstand der Strahlenquelle von 30 cm, unter gleichzeitiger Einwirkung eines Magnetfeldes parallel zur Strahlenrichtung. Die Bestrahlungszeit beträgt 1 Minute. Example 1: 2 g of dry powder from fetal beef liver, the anhydrous acid vapor lysis in a vacuum according to the described process Normal temperature was obtained, be energetically stimulated. To do this, first the absorption spectrum is determined photometrically, then the irradiation with a Radiation source carried out, which the wavelengths or frequencies of the main Contain absorption maxima. The dry powder is in a sterile cuvette in a layer thickness of 2 mm and covered with a quartz plate. The irradiation takes place with a radiation source with wavelengths between 200 to 1000 nm at a distance the radiation source of 30 cm, with simultaneous action of a magnetic field parallel to the direction of the beam. The irradiation time is 1 minute.
Beispiel 2: Es sollen wässrige Extrakte aus demnach Beispiel 1 gewonnenen Trockensubstanzen bei der Ampullierung energetisch angeregt werden. Dabei wird das flüssige Füllgut in einem chemisch inerten Schlauch durch eine Durchlaufküvette bzw. -kammer mit Quarzfenster geleitet, bevor es in Ampullen abgefüllt wird. Example 2: Aqueous extracts from example 1 are to be obtained Dry substances are energetically stimulated during the ampoule. It will liquid filling material in a chemically inert tube through a flow cell or chamber with quartz window before it is filled into ampoules.
Durch das Quarzfenster erfolgt die Bestrahlung mit Impulsloser in der Wellenlänge einer hauptsächlichen Absorptionsbande des Ablsorptionspektrums des Füllguts. Durch den konstanten Durchlauf und die Abstimmung der Strahlungsintensität wird eine Wärmestauung vermieden.Irradiation with impulse less takes place through the quartz window in the wavelength of a main absorption band of the absorption spectrum of the product. Due to the constant flow and the coordination of the radiation intensity a build-up of heat is avoided.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782842691 DE2842691A1 (en) | 1978-09-30 | 1978-09-30 | Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782842691 DE2842691A1 (en) | 1978-09-30 | 1978-09-30 | Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2842691A1 true DE2842691A1 (en) | 1980-04-10 |
Family
ID=6050994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19782842691 Withdrawn DE2842691A1 (en) | 1978-09-30 | 1978-09-30 | Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE2842691A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0469661A1 (en) * | 1990-08-01 | 1992-02-05 | Enza Ciccolo | Method for the indentification of frequency and bioenergetic activities in waters and their use |
US5482600A (en) * | 1994-06-10 | 1996-01-09 | Somerville Technology Group, Inc. | Process to improve color in antiperspirant solutions |
WO1997001355A1 (en) * | 1995-06-26 | 1997-01-16 | Antonio Sacchetti | Magnetic or electromagnetically induced energization of natural substances |
BE1012725A5 (en) * | 1998-09-17 | 2001-02-06 | Kozo Niwaniwa Kozo | Method of enhancing antitumor activity of medication gross, gross composition containing medication enhancing antitumor activity, method for evaluating effectiveness tumor treatment of pig medication, and method of evaluation of the effectiveness of antitumor gross medication. |
EP1478396A1 (en) * | 2002-01-31 | 2004-11-24 | Chemstop Pty Ltd | Process for the preparation of a nutrient formulation |
WO2007137833A1 (en) * | 2006-05-30 | 2007-12-06 | Gerald Jentsch | Specifically adapted plant-derived redox catalyst and method for the production thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB275183A (en) * | 1926-07-28 | 1928-09-21 | Georg Eichelbaum | A process for the treatment of animal glands and the like to increase the activity of the hormones |
DE1805284A1 (en) * | 1967-10-25 | 1969-10-16 | Kindt Flyborg | Process for the preparation of vibration carriers as a means for the detection and treatment of diseases |
US3575831A (en) * | 1967-05-31 | 1971-04-20 | Hoffmann La Roche | Process for the production of vitamin d |
DE1692771A1 (en) * | 1968-02-24 | 1972-01-05 | Willy Dr Med Seuss | Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them |
DE2643215A1 (en) * | 1976-09-25 | 1978-04-06 | Bayer Ag | CANCEROSTATICALLY EFFECTIVE PREPARATIONS FROM TUMOR CELLS AND A METHOD FOR THEIR PRODUCTION |
-
1978
- 1978-09-30 DE DE19782842691 patent/DE2842691A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB275183A (en) * | 1926-07-28 | 1928-09-21 | Georg Eichelbaum | A process for the treatment of animal glands and the like to increase the activity of the hormones |
US3575831A (en) * | 1967-05-31 | 1971-04-20 | Hoffmann La Roche | Process for the production of vitamin d |
DE1805284A1 (en) * | 1967-10-25 | 1969-10-16 | Kindt Flyborg | Process for the preparation of vibration carriers as a means for the detection and treatment of diseases |
DE1692771A1 (en) * | 1968-02-24 | 1972-01-05 | Willy Dr Med Seuss | Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them |
DE2643215A1 (en) * | 1976-09-25 | 1978-04-06 | Bayer Ag | CANCEROSTATICALLY EFFECTIVE PREPARATIONS FROM TUMOR CELLS AND A METHOD FOR THEIR PRODUCTION |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0469661A1 (en) * | 1990-08-01 | 1992-02-05 | Enza Ciccolo | Method for the indentification of frequency and bioenergetic activities in waters and their use |
US5482600A (en) * | 1994-06-10 | 1996-01-09 | Somerville Technology Group, Inc. | Process to improve color in antiperspirant solutions |
WO1997001355A1 (en) * | 1995-06-26 | 1997-01-16 | Antonio Sacchetti | Magnetic or electromagnetically induced energization of natural substances |
BE1012725A5 (en) * | 1998-09-17 | 2001-02-06 | Kozo Niwaniwa Kozo | Method of enhancing antitumor activity of medication gross, gross composition containing medication enhancing antitumor activity, method for evaluating effectiveness tumor treatment of pig medication, and method of evaluation of the effectiveness of antitumor gross medication. |
ES2155802A1 (en) * | 1998-09-17 | 2001-05-16 | Kozo Niwa | Activating antitumour polysaccharide drugs |
EP1478396A1 (en) * | 2002-01-31 | 2004-11-24 | Chemstop Pty Ltd | Process for the preparation of a nutrient formulation |
EP1478396A4 (en) * | 2002-01-31 | 2010-08-25 | Chemstop Pty Ltd | Process for the preparation of a nutrient formulation |
WO2007137833A1 (en) * | 2006-05-30 | 2007-12-06 | Gerald Jentsch | Specifically adapted plant-derived redox catalyst and method for the production thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pakhomov et al. | Current state and implications of research on biological effects of millimeter waves: a review of the literature | |
Karu et al. | Biostimulation of HeLa cells by low-intensity visible light | |
DE102014108584B4 (en) | Process for the preparation of a consumable intended for evaporation | |
US5166176A (en) | Composition for healing damaged skin | |
DE2515697A1 (en) | PHOTOCHEMICAL STIMULATION OF NERVES | |
DE2842691A1 (en) | Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field | |
DD209967A5 (en) | METHOD FOR PRODUCING SKIN-ADHESIVE, PARTICULARLY MUSCLE-BREAST-FLOATING PREPARATES | |
WO1999021614A1 (en) | Device and method for activating objects | |
Kuzin et al. | Stimulation of plant growth by exposure to low level γ-radiation and magnetic field, and their possible mechanism of action | |
Karu et al. | Control of RNA synthesis rate in tumor cells HeLa by action of low-intensity visible light of copper laser | |
DE29724780U1 (en) | Electromagnetic oscillation amplifier especially a laser for biological system treatment | |
DE2360647B2 (en) | PROCESS FOR PRODUCING AN IMMOBILIZED ENZYME BY GELATINIZATION | |
Stumm et al. | Histone bei dem Phycomyceten Allomyces arbuscula (Butl.) | |
Jaski et al. | Electromagnetic Radiation as a Tool in the Life Sciences: Radio waves, long used for communications, are becoming an important tool in biophysics research. | |
DE1767267A1 (en) | Process for pasteurizing biochemical working material and increasing the fermentation yield | |
DE2819131C2 (en) | ||
Reed III et al. | Microwave irradiation of the isolated rat heart after treatment with ANS blocking agents | |
DE102018124666A1 (en) | Method for stimulating the growth of biomass contained in a liquid within a bioreactor | |
DE19838304A1 (en) | Medium for photo-therapy in humans and animals comprises a suitable carrier with luminescence placed at or near the treatment site to be exposed to defined doses of ultra violet C light | |
EP0266437A1 (en) | Process and apparatus for neutralizing toxins and pollutants, especially products and objects which cause allergies when contacted by humans | |
Proctor et al. | Preservation of foods by irradiation | |
DE2220065A1 (en) | Microbiological culture nutrient - for cell growth esp of mammal cells in vivo | |
DE4122380A1 (en) | Carcinoma therapy appts. for treatment of tumours - uses low frequency magnetic alternating field with field strength of at least 6 milli-tesla in region of tumour to be treated | |
EP0842424B1 (en) | Process for determining the effectiveness and tolerance of a xenogenic substance administered to an organism | |
Lopp et al. | Fluorescence method for the measurement of penetration and metabolism of carcinogens in mouse skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8130 | Withdrawal |